BridgeBio Bounces Back with Promising Canavan, MD Data

After suffering a blow to its multi-billion dollar liver cancer program, BridgeBio presented early but promising data in ultra-rare Canavan disease.

Related Keywords

,Guangping Gao ,Suma Sinha ,International Hybrid Annual Congress ,Child Neurology Society ,World Muscle Society ,Ml Bio Solutions ,Helsinn Healthcare ,Aspa Therapeutics ,Neurology Society ,Canavan Disease Rating Scale ,Milestone Checklist ,Positive Data ,Limb Girdle Muscular Dystrophy Type ,World Muscle ,Resume ,Careers ,Ridgebio Bounces Back With Promising Canavan ,End Data ,Iospace ,Advice ,